• Sherry K Milfred-LaForest, Julie A Gee, Adam M Pugacz, Ileana L Piña, Danielle M Hoover, Robert C Wenzell, Aubrey Felton, Eric Guttenberg, and Jose Ortiz.
• Department of Pharmacy, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, United States. Electronic address: Sharon.Laforest@va.gov.
• Prog Cardiovasc Dis. 2017 Sep 1; 60 (2): 249-258.

ObjectiveTo perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients.BackgroundTransitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and symptoms. We hypothesized that combining these elements with optimization of medications would impact outcomes.MethodsIn the SERIOUS HF Medication Reconciliation Transitional Care Clinic (HF MRTCC), patients were seen by a clinical pharmacist trained in HF. The pharmacist performed medication reconciliation, a basic physical exam, and a HF symptom history. Medications were adjusted by the clinical pharmacist or medical provider. Data were retrospectively collected for a quality improvement evaluation of this novel clinic on medication discrepancies, medications optimized, and 30-day readmissions. Descriptive statistics and paired t-tests were used for medication doses.ResultsAll patients (n=135) had a diagnosis of HF, 59% were recently discharged. The mean time from discharge to the clinic appointment was 10±6days, and the 30day all-cause readmission rate was 9%. Medication discrepancies were detected in 53% of patients. Medications were optimized in 70%, most frequently beta blockers, ace inhibitors, and diuretics. In patients with an ejection fraction ≤40%, significantly higher doses of beta blockers and ace inhibitors were prescribed after the clinic visit.ConclusionThe HF MRTCC identified and corrected numerous medication discrepancies, up-titrated medications, and was associated with a 30-day readmission rate of 9%. These encouraging pilot results are hypothesis-generating and warrant further controlled trials.Published by Elsevier Inc.

38 keywords...

hide…